Author
Abstract
This study examines the relationship between board gender diversity and R&D investments in the UK. Also, the study goes deeper and examines whether the relationship between board gender diversity and R&D investments is affected by the female tenure in the board. Using a sample from the UK FTSE350 index between 2009 and 2018, the findings show that board gender diversity has a positive impact on R&D intensity. Importantly, we find that this relationship is not affected by the tenure of female directors. Therefore, this result alleviates the concern that long female tenure might lead to weak monitoring, thereby adversely impacting the relationship between gender diversity and R&D investments. The findings hold after using different proxies for gender diversity and after controlling for endogeneity. The study injects the literature with up-to-date evidence on the role of female directors in R&D investment in the UK where female representation in the board is still optional. Moreover, the findings of this study contribute to the merits of the tense debate on female representation in the board of directors. In this regard, given that the current regulations in the UK recommend, but do not oblige, board gender diversity, regulatory bodies (e.g., FRC) could take this issue into consideration for future governance reform. Furthermore, companies that are eager to maintain sustained innovation should pay close attention to gender diversity during the process of the directors’ appointment.
Suggested Citation
Ala’a Azzam, 2022.
"Board gender diversity and innovation activities: Evidence from R&D investments in the UK,"
Cogent Business & Management, Taylor & Francis Journals, vol. 9(1), pages 2154056-215, December.
Handle:
RePEc:taf:oabmxx:v:9:y:2022:i:1:p:2154056
DOI: 10.1080/23311975.2022.2154056
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:oabmxx:v:9:y:2022:i:1:p:2154056. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://cogentoa.tandfonline.com/OABM20 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.